Skip to main content
Journal cover image

Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis

Publication ,  Conference
Harrison, SA; Abdelmalek, MF; Diehl, AM; Caldwell, S; Shiffman, ML; Ghalib, R; Lawitz, E; Rockey, DC; Schall, REA; Jia, C; McColgan, BJ ...
Published in: HEPATOLOGY
October 1, 2017

Duke Scholars

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

October 1, 2017

Volume

66

Start / End Page

1120A / 1121A

Location

Washington, DC

Publisher

WILEY

Conference Name

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Harrison, S. A., Abdelmalek, M. F., Diehl, A. M., Caldwell, S., Shiffman, M. L., Ghalib, R., … Sanyal, A. J. (2017). Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis. In HEPATOLOGY (Vol. 66, pp. 1120A-1121A). Washington, DC: WILEY.
Harrison, Stephen A., Manal F. Abdelmalek, Anna Mae Diehl, Stephen Caldwell, Mitchell L. Shiffman, Reem Ghalib, Eric Lawitz, et al. “Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis.” In HEPATOLOGY, 66:1120A-1121A. WILEY, 2017.
Harrison SA, Abdelmalek MF, Diehl AM, Caldwell S, Shiffman ML, Ghalib R, et al. Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis. In: HEPATOLOGY. WILEY; 2017. p. 1120A-1121A.
Harrison SA, Abdelmalek MF, Diehl AM, Caldwell S, Shiffman ML, Ghalib R, Lawitz E, Rockey DC, Schall REA, Jia C, McColgan BJ, Myers RP, Subramanian M, McHutchison JG, Muir AJ, Ratziu V, Afdhal NH, Goodman ZD, Bosch J, Sanyal AJ. Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis. HEPATOLOGY. WILEY; 2017. p. 1120A-1121A.
Journal cover image

Published In

HEPATOLOGY

EISSN

1527-3350

ISSN

0270-9139

Publication Date

October 1, 2017

Volume

66

Start / End Page

1120A / 1121A

Location

Washington, DC

Publisher

WILEY

Conference Name

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics